GO:0071726 cellular response to diacyl bacterial lipopeptide: Innate Immune Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071726 describes how a cell changes its state or activity in response to diacylated bacterial lipopeptides, a major class of microbe-associated molecular patterns [1,2].
• Diacyl lipopeptides are sensed primarily by TLR2 heterodimers with TLR6 or TLR1, and in some species by TLR15, triggering NF-kB and inflammatory cytokine production [2,3,4,5,6].
• The response is cell-type specific: keratinocytes, epithelial cells, and stromal cells all mount distinct inflammatory outputs upon diacyl lipopeptide exposure [1,7].
• Dysregulated diacyl lipopeptide sensing contributes to atopic dermatitis, endometritis, and other inflammatory conditions [1,7].
• Key experimental approaches include TLR2/6 knockout models, NF-kB reporter assays, cytokine profiling, and biosensor-based detection.
• EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression, and library screening services to dissect this pathway.
Description
The Gene Ontology term GO:0071726, cellular response to diacyl bacterial lipopeptide, defines the set of cellular processes triggered when a cell encounters a diacylated bacterial lipopeptide [1,2]. Diacyl lipopeptides are structural components of bacterial membranes and lipoproteins, and they act as potent microbe-associated molecular patterns (MAMPs) that alert the innate immune system to Gram-positive and mycoplasma infections [2,5]. The response encompasses changes in gene expression, cytokine secretion, cytoskeletal rearrangement, and metabolic reprogramming that together coordinate host defense [1,7]. Researchers study GO:0071726 because it sits at the interface of microbial recognition and inflammatory disease. The pathway is initiated by pattern-recognition receptors, most notably Toll-like receptor 2 (TLR2) in complex with TLR6 or TLR1, which discriminate diacyl from triacyl lipopeptides [2,3,4,6]. Downstream signaling converges on NF-kB, MAP kinases, and inflammasome-related outputs, making this term central to understanding both protective immunity and pathological inflammation [1,5,7]. Because the response is highly context-dependent, cell-type-specific models are essential. Keratinocytes, endometrial epithelial cells, and stromal fibroblasts each exhibit distinct sensitivity and effector programs upon diacyl lipopeptide stimulation [1,7]. This article synthesizes the current mechanistic understanding of GO:0071726, highlights the genes and diseases involved, and outlines CRISPR-based strategies for functional dissection.
cellular response to diacyl bacterial lipopeptide At A Glance
| GO ID | GO:0071726 |
|---|---|
| GO term | cellular response to diacyl bacterial lipopeptide |
| Ontology | biological_process |
| Synonym | cellular response to diacylated bacterial lipoprotein |
| Major function | Detection of diacylated bacterial lipopeptides and initiation of intracellular signaling cascades that alter gene expression, cytokine secretion, and cellular activity [1,2,5] |
| Primary receptors | TLR2 in heterodimers with TLR6 or TLR1; TLR15 in avian species [2,3,4,5,6] |
| Key downstream pathways | NF-kB, MAPK, and inflammasome-associated signaling [1,5,7] |
| Cell types involved | Keratinocytes, epithelial cells, stromal cells, and innate immune cells [1,7] |
| Disease relevance | Atopic dermatitis, endometritis, and other inflammatory disorders [1,7] |
What Is GO:0071726?
GO:0071726 is a biological process term describing any change in a cell's state or activity, including movement, secretion, enzyme production, or gene expression, that occurs as a result of exposure to a diacylated bacterial lipopeptide [1,2]. It is the cellular-level counterpart to the broader organismal response to these lipopeptides and is synonymous with cellular response to diacylated bacterial lipoprotein.
Why Is cellular response to diacyl bacterial lipopeptide Important in Cell Biology?
GO:0071726 is important because it defines the earliest cellular decisions that shape innate immune responses to a major class of bacterial molecules. Understanding this process illuminates how the host distinguishes different lipopeptide structures, why certain cell types are hyperresponsive in inflammatory diseases, and how to design therapeutics that modulate TLR2-driven inflammation without compromising antimicrobial defense [1,2,7].
• Diacyl lipopeptides are potent MAMPs that activate TLR2/TLR6 and TLR2/TLR1 heterodimers, making this term central to bacterial recognition [2,3,4,6].
• The response controls secretion of IL-33, IL-6, TNF, and other cytokines that orchestrate inflammation [1,7].
• Dysregulation is linked to atopic dermatitis, where soluble lipopeptides can suppress gasdermin D-associated IL-33 release.
• In bovine endometrium, epithelial and stromal cells initiate inflammatory responses to lipopeptides via TLR2, TLR1, and TLR6, relevant to uterine disease.
• Mycoplasma synoviae diacyl lipopeptides trigger TLR15-dependent innate responses, highlighting species-specific sensing.
• TLR1- and TLR6-independent recognition of certain lipopeptides reveals additional complexity in the pathway.
• Biosensor development for Gram-positive bacteria exploits TLR2/6-dependent lipopeptide detection.
• The pathway is a target for anti-inflammatory drug discovery and vaccine adjuvant design [1,2].
• CRISPR models of TLR2, TLR6, and downstream effectors enable causal dissection of the response [2,4].
• Single-cell and spatial transcriptomics can resolve cell-type-specific contributions to GO:0071726 in tissues [1,7].
What Happens During cellular response to diacyl bacterial lipopeptide?
Recognition by TLR2 Heterodimers
In simple terms: The cell first detects the bacterial lipopeptide using a receptor pair on its surface.
Diacylated bacterial lipopeptides are recognized primarily by Toll-like receptor 2 (TLR2) in complex with TLR6, and in some contexts with TLR1 [2,3,4,6]. Structural discrimination between diacyl and triacyl lipopeptides depends on the heterodimer composition, with TLR2/TLR6 favoring diacyl species and TLR2/TLR1 favoring triacyl species [2,6]. In avian species, TLR15 serves as an additional sensor for diacyl lipopeptides from Mycoplasma synoviae. This recognition step is the initiating event of GO:0071726 and determines the specificity of the downstream response [2,5].
Intracellular Signaling Cascade Activation
In simple terms: Once the receptor binds the lipopeptide, it sends a signal inside the cell that turns on inflammatory genes.
Ligand binding induces TLR2 heterodimerization and recruitment of adaptor proteins, leading to activation of NF-kB and MAP kinase pathways [2,7]. This signaling cascade results in changes in gene expression, enzyme production, and secretion of inflammatory mediators [1,7]. In keratinocytes, this pathway intersects with gasdermin D-associated IL-33 release, which can be suppressed by soluble bacterial lipopeptides. The signaling output is cell-type specific, with epithelial and stromal cells of the bovine endometrium mounting distinct inflammatory responses via TLR2, TLR1, and TLR6.
Effector Responses: Cytokine Secretion and Gene Expression
In simple terms: The activated cell releases cytokines and changes which genes it expresses to fight the infection.
Downstream of receptor activation, cells secrete pro-inflammatory cytokines such as IL-6, TNF, and IL-33, and upregulate antimicrobial genes [1,7]. In atopic dermatitis models, diacyl lipopeptide signaling modulates IL-33 release in a gasdermin D-dependent manner. The response also includes changes in cell movement and enzyme production as defined by GO:0071726 [1,2]. These effector outputs are critical for host defense but can also drive pathological inflammation when dysregulated [1,7].
Cell-Type-Specific and Species-Specific Variations
In simple terms: Different cell types and different animal species respond to the same lipopeptide in different ways.
The cellular response to diacyl bacterial lipopeptide is not uniform. Keratinocytes, endometrial epithelial cells, and stromal fibroblasts each exhibit distinct sensitivity and effector programs [1,7]. Species differences are also evident: TLR15 mediates diacyl lipopeptide recognition in chickens, while mammals rely on TLR2/TLR6. Additionally, some lipopeptides can be recognized independently of TLR1 and TLR6, indicating alternative or additional recognition mechanisms. These variations are important for interpreting experimental models and for translational research [3,5,7].
Key Genes Involved in GO:0071726 cellular response to diacyl bacterial lipopeptide
The following genes and proteins are central to the recognition, signaling, and effector phases of GO:0071726.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR2 | Core receptor for diacyl lipopeptides; forms heterodimers with TLR6 or TLR1 [2,6] | Knockout and point-mutation models to dissect ligand specificity and signaling [2,6] |
| TLR6 | Partners with TLR2 to preferentially recognize diacyl lipopeptides [2,4] | Knockout models show loss of diacyl lipopeptide responses |
| TLR1 | Partners with TLR2; contributes to recognition of some lipopeptides [2,3,6] | Knockout and overexpression studies reveal TLR1-dependent and independent pathways [3,6] |
| TLR15 | Avian-specific sensor for diacyl lipopeptides from Mycoplasma synoviae | Knockdown and overexpression in chicken cells to study species-specific immunity |
| MYD88 | Adaptor protein downstream of TLR2 heterodimers [2,7] | Knockout models to block NF-kB activation and cytokine production [2,7] |
| NFKB1 | Transcription factor driving inflammatory gene expression [1,7] | Reporter assays and knockout models to measure pathway activation [1,7] |
| MAPK1 | Kinase involved in MAPK signaling downstream of TLR2 | Phospho-specific antibodies and inhibitors to probe signaling |
| MAPK3 | Kinase involved in MAPK signaling downstream of TLR2 | Phospho-specific antibodies and inhibitors to probe signaling |
| IL6 | Pro-inflammatory cytokine secreted upon activation [1,7] | ELISA and reporter assays to quantify response [1,7] |
| TNF | Pro-inflammatory cytokine secreted upon activation [1,7] | ELISA and reporter assays to quantify response [1,7] |
| IL33 | Alarmin released in keratinocytes; linked to gasdermin D | Knockout and overexpression models in atopic dermatitis research |
| GSDMD | Gasdermin D; mediates IL-33 release in keratinocytes | Knockout models to study pyroptosis-like release |
| TLR2/TLR6 heterodimer | Functional receptor complex for diacyl lipopeptides [2,4] | Co-immunoprecipitation and FRET to study assembly [2,4] |
| TLR2/TLR1 heterodimer | Functional receptor complex for triacyl lipopeptides [2,6] | Comparative studies to understand ligand discrimination [2,6] |
| CD14 | Co-receptor that enhances TLR2 signaling | Overexpression and knockdown to modulate sensitivity |
| CD36 | Co-receptor for some TLR2 ligands | Knockout models to test ligand specificity |
| TIRAP | Adaptor protein in TLR2 signaling | Knockout models to dissect MyD88-dependent pathways |
| TRAF6 | E3 ubiquitin ligase downstream of TLR2 | Knockout and point-mutation models to study NF-kB activation |
How Is cellular response to diacyl bacterial lipopeptide Regulated?
The cellular response to diacyl bacterial lipopeptides is regulated at multiple levels. Receptor expression levels of TLR2, TLR6, and TLR1 modulate sensitivity to lipopeptides [2,3,4]. Soluble bacterial lipopeptides can suppress gasdermin D-associated IL-33 release in keratinocytes, indicating negative feedback regulation. Additionally, TLR1- and TLR6-independent recognition pathways suggest that alternative regulatory mechanisms exist. In bovine endometrial cells, the inflammatory response is regulated by the relative abundance of TLR2, TLR1, and TLR6. These regulatory layers ensure that the response is appropriately scaled to the microbial threat.
cellular response to diacyl bacterial lipopeptide and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR2 | Atopic dermatitis; bacterial infection susceptibility [1,2] | Keratinocyte-specific knockout mice |
| TLR6 | Inflammatory skin diseases; endometritis [4,7] | TLR6 knockout bovine endometrial cells |
| GSDMD | Atopic dermatitis; IL-33 release | GSDMD knockout keratinocytes |
| IL33 | Atopic dermatitis; type 2 inflammation | IL33 reporter mice |
| TLR15 | Mycoplasma infections in poultry | Chicken TLR15 knockdown cell lines |
Atopic Dermatitis
Diacyl lipopeptide signaling in keratinocytes contributes to atopic dermatitis pathogenesis. Soluble bacterial lipopeptides suppress gasdermin D-associated IL-33 release in keratinocytes and ameliorate atopic dermatitis in mice, highlighting the therapeutic potential of modulating this pathway.
Endometritis and Reproductive Tract Inflammation
Epithelial and stromal cells of the bovine endometrium initiate inflammatory responses to bacterial lipopeptides via TLR2, TLR1, and TLR6, implicating GO:0071726 in endometritis and uterine disease.
Mycoplasma Infections
Diacylated lipopeptides from Mycoplasma synoviae mediate TLR15-induced innate immune responses, linking this GO term to mycoplasma-associated diseases in poultry and potentially other species.
Bacterial Detection and Diagnostics
TLR2/6-dependent recognition of diacyl lipopeptides has been exploited to develop biosensors for Gram-positive bacterial detection, demonstrating the translational relevance of this pathway.
From cellular response to diacyl bacterial lipopeptide-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TLR2 mediate diacyl lipopeptide sensing? | TLR2 knockout cell line or mouse [2,6] |
| Is TLR6 required for diacyl versus triacyl discrimination? | TLR6 knockout and point-mutation models |
| What is the role of GSDMD in IL-33 release? | GSDMD knockout keratinocytes |
| Can soluble lipopeptides suppress inflammation? | Overexpression of soluble lipopeptide in mouse models |
| How does TLR15 recognize Mycoplasma lipopeptides? | TLR15 knock-in or overexpression in chicken cells |
| What downstream genes are activated? | NF-kB reporter knock-in and RNA-seq [1,7] |
How to Study the cellular response to diacyl bacterial lipopeptide Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identifying pathway targets in stimulated cells [1,7] |
| ELISA | Cytokine secretion | Quantifying IL-6, TNF, IL-33 release [1,7] |
| NF-kB luciferase reporter | NF-kB transcriptional activity | Screening for pathway activators or inhibitors [2,7] |
| Western blot | Phosphorylation of MAPK and IkB | Confirming signaling activation [2,7] |
| Co-immunoprecipitation | TLR2 heterodimer assembly | Studying receptor complex formation [2,4] |
| Flow cytometry | Surface TLR expression | Assessing receptor levels on different cell types |
| Biosensor assay | Lipopeptide detection | Gram-positive bacterial detection |
| CRISPR screening | Genes required for the response | Unbiased discovery of pathway components [2,4] |
Transcriptomic Profiling
RNA-seq of cells stimulated with diacyl lipopeptides reveals the gene expression changes that define GO:0071726. This approach has been used to identify inflammatory mediators in keratinocytes and endometrial cells [1,7].
Cytokine and Chemokine Quantification
ELISA and multiplex assays measure secretion of IL-6, TNF, IL-33, and other effectors. These methods are standard for assessing the functional output of the pathway [1,7].
Reporter Assays for NF-kB and MAPK
Luciferase reporters and phospho-specific antibodies quantify activation of NF-kB and MAPK pathways downstream of TLR2 heterodimers [2,7].
Biosensor-Based Detection
TLR2/6-based biosensors have been developed for Gram-positive bacterial detection, providing a rapid readout of lipopeptide recognition.
How CRISPR Can Be Used to Study GO:0071726 cellular response to diacyl bacterial lipopeptide
Knockout
CRISPR knockout of TLR2, TLR6, TLR1, MYD88, or GSDMD in cell lines or primary cells can abolish or attenuate the cellular response to diacyl bacterial lipopeptides, providing causal evidence for their roles [2,4,6]. For example, TLR6 knockout cells fail to respond to diacyl lipopeptides, confirming its essential function.
Point Mutation
Point mutations in TLR2 or TLR6 ligand-binding domains can dissect the structural basis of diacyl lipopeptide recognition. Such models help distinguish between TLR1- and TLR6-dependent pathways [3,6].
Knock-in
Knock-in of reporter genes such as luciferase or fluorescent proteins into NF-kB target loci enables real-time monitoring of pathway activation in response to lipopeptides [1,7]. Tagged knock-in of TLR2 or TLR6 allows visualization of receptor trafficking.
Overexpression
Overexpression of TLR2, TLR6, or TLR15 in heterologous cells can confer responsiveness to diacyl lipopeptides, enabling structure-function studies and species-specific comparisons [5,6].
How EDITGENE Supports cellular response to diacyl bacterial lipopeptide Research
Researchers studying cellular response to diacyl bacterial lipopeptide-related genes often need to determine whether a candidate gene is causally involved in recognition, signaling, or effector output. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for cellular response to diacyl bacterial lipopeptide research.
Frequently Asked Questions About cellular response to diacyl bacterial lipopeptide
What is GO:0071726?
GO:0071726 is the Gene Ontology term for cellular response to diacyl bacterial lipopeptide, describing how a cell changes its state or activity upon exposure to diacylated bacterial lipopeptides [1,2].
What genes are involved in cellular response to diacyl bacterial lipopeptide?
Key genes include TLR2, TLR6, TLR1, TLR15, MYD88, NFKB1, MAPK1, MAPK3, IL6, TNF, IL33, and GSDMD [1,2,4,5,6,7].
Which receptors recognize diacyl bacterial lipopeptides?
TLR2 in heterodimers with TLR6 or TLR1, and in avian species TLR15, recognize diacyl lipopeptides [2,3,4,5,6].
How does TLR2/TLR6 discriminate diacyl from triacyl lipopeptides?
TLR2/TLR6 heterodimers preferentially bind diacyl lipopeptides, while TLR2/TLR1 heterodimers favor triacyl species, based on structural differences in the lipid chains [2,6].
What diseases are associated with dysregulated diacyl lipopeptide response?
Atopic dermatitis, endometritis, and mycoplasma infections have been linked to this pathway [1,5,7].
How can I study GO:0071726 in the lab?
Common methods include RNA-seq, cytokine ELISA, NF-kB reporter assays, and CRISPR knockout models [1,2,7].
What is the role of GSDMD in this pathway?
GSDMD mediates IL-33 release in keratinocytes upon diacyl lipopeptide stimulation, and soluble lipopeptides can suppress this release.
Are there species-specific differences in diacyl lipopeptide sensing?
Yes, TLR15 mediates recognition in chickens, while mammals primarily use TLR2/TLR6.
Can CRISPR be used to study this pathway?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the pathway [2,4,6].
What cell types respond to diacyl bacterial lipopeptides?
Keratinocytes, epithelial cells, stromal cells, and innate immune cells all respond, with cell-type-specific outputs [1,7].
Conclusion
GO:0071726 captures a fundamental innate immune process by which cells detect and respond to diacylated bacterial lipopeptides. The pathway is initiated by TLR2 heterodimers and TLR15, leading to NF-kB and MAPK activation, cytokine secretion, and gene expression changes that are critical for host defense but can also drive inflammatory disease [1,2,5,7]. Continued research using CRISPR models and multi-omic approaches will refine our understanding of this response and its therapeutic potential.
References
- 1. Williams H et al.. 2026. Soluble bacterial lipopeptides suppress gasdermin D-associated IL-33 release in keratinocytes and atopic dermatitis in mice.. Nat Commun 17(1) PMID: 42129169
- 2. Takeda K et al.. 2002. Recognition of lipopeptides by Toll-like receptors.. J Endotoxin Res 8(6):459-63 PMID: 12697090
- 3. Buwitt-Beckmann U et al.. 2006. TLR1- and TLR6-independent recognition of bacterial lipopeptides.. J Biol Chem 281(14):9049-57 PMID: 16455646
- 4. Takeuchi O et al.. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6.. Int Immunol 13(7):933-40 PMID: 11431423
- 5. Oven I et al.. 2013. Diacylated lipopeptide from Mycoplasma synoviae mediates TLR15 induced innate immune responses.. Vet Res 44(1):99 PMID: 24134665
- 6. Takeuchi O et al.. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.. J Immunol 169(1):10-4 PMID: 12077222
- 7. Turner ML et al.. 2014. Epithelial and stromal cells of bovine endometrium have roles in innate immunity and initiate inflammatory responses to bacterial lipopeptides in vitro via Toll-like receptors TLR2, TLR1, and TLR6.. Endocrinology 155(4):1453-65 PMID: 24437488
- 8. McLeod J et al.. 2020. Developing a toll-like receptor biosensor for Gram-positive bacterial detection and its storage strategies.. Analyst 145(18):6024-6031 PMID: 32724992
